GWAS for Breast Cancer Chemotherapy Toxicities in S0221
Anthropometry (1)
- bmi - Body mass index at enrollment (phv00395482.v1.p1)
Demographics (2)
- age - Age at enrollment (phv00395481.v1.p1)
- female - Female gender of participant (phv00395483.v1.p1)
Race and Ethnicity (7)
- ethnicHisp - Hispanic ethnicity of participant (phv00395490.v1.p1)
- raceasian - Asian race of participant (phv00395485.v1.p1)
- raceblack - Black race of participant (phv00395484.v1.p1)
- racenative - Native race of participant (phv00395487.v1.p1)
- racepacific - Pacific Islander race of participant (phv00395486.v1.p1)
- raceunknown - Unnown race of participant (phv00395489.v1.p1)
- racewhite - White race of participant (phv00395488.v1.p1)
Other (14)
- AFFECTION_STATUS - Status of taxanes-related neuropathy (phv00395475.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00395494.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00395493.v1.p1)
- CONSENT - Consent group as determined by DAC - DS-Breast Ca-COL (phv00395474.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00395495.v1.p1)
- IS_TUMOR - Tumor status (phv00395496.v1.p1)
- NeuroTox_T - Peripheral neurological toxicity during the taxanes treatment segment (phv00395491.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00395492.v1.p1)
- SAMPLE_ID - Sample ID (phv00395477.v1.p1)
- SAMPLE_USE - Sample Use (phv00395478.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00395479.v1.p1)
- SUBJECT_ID - Subject ID (phv00395473.v1.p1)
- SUBJECT_ID - Subject ID (phv00395476.v1.p1)
- TRNO - Treatment arm (phv00395480.v1.p1)